Enhanced polymorphonuclear neutrophil-mediated endothelial cell injury and its relation to high surgical mortality

Y Shimizu1, M Miyazaki, H Ito

  • 1First Department of Surgery, School of Medicine, Chiba University, Japan.

Abstract

Insights

Polymorphonuclear neutrophils (PMN) show increased injury potential in cirrhosis patients, contributing to higher postoperative complications after liver surgery. This PMN "priming" highlights a key factor in surgical outcomes for liver disease.

Area of Science:

  • Hepatology
  • Immunology
  • Vascular Biology

Background:

  • Patients with cirrhosis exhibit a high incidence of postoperative complications after surgery.
  • Polymorphonuclear neutrophils (PMN) can injure vascular endothelium and cause organ damage.
  • Altered PMN function is observed in cirrhosis, but their role in post-hepatectomy complications is under-investigated.

Purpose of the Study:

  • To evaluate the potential of PMN to cause endothelial cell injury in patients with cirrhosis.
  • To investigate the link between PMN-mediated endothelial damage and postoperative complications in cirrhosis.

Main Methods:

  • Hepatic resection was performed on patients with normal liver and metastatic liver carcinoma, and patients with cirrhosis and hepatocellular carcinoma.
  • PMN were isolated from patients pre-operation and co-cultured with human umbilical vein endothelial cells.
  • Lactate dehydrogenase (LDH), thrombomodulin release, and PMN elastase activity were measured.

Main Results:

  • Cirrhosis patients showed significantly higher release of LDH and thrombomodulin compared to normal liver patients.
  • PMN elastase activity was also significantly elevated in the cirrhosis group.
  • Surgical morbidity was 50% in cirrhosis patients versus 0% in normal liver patients.

Conclusions:

  • PMN possess an enhanced capacity for endothelial cell injury in patients with cirrhosis.
  • This PMN "priming" is a likely contributor to the increased postoperative complications observed after hepatectomy in cirrhosis patients.

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...